Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease. / Gödel, Clemens; Kunkel, Birgit; Kashani, Alireza; Lassmann, Hans; Arumugam, Manimozhiyan; Krishnamoorthy, Gurumoorthy.

I: Journal of Neuroinflammation, Bind 17, Nr. 1, 2020, s. 79.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Gödel, C, Kunkel, B, Kashani, A, Lassmann, H, Arumugam, M & Krishnamoorthy, G 2020, 'Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease', Journal of Neuroinflammation, bind 17, nr. 1, s. 79. https://doi.org/10.1186/s12974-020-01766-9

APA

Gödel, C., Kunkel, B., Kashani, A., Lassmann, H., Arumugam, M., & Krishnamoorthy, G. (2020). Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease. Journal of Neuroinflammation, 17(1), 79. https://doi.org/10.1186/s12974-020-01766-9

Vancouver

Gödel C, Kunkel B, Kashani A, Lassmann H, Arumugam M, Krishnamoorthy G. Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease. Journal of Neuroinflammation. 2020;17(1):79. https://doi.org/10.1186/s12974-020-01766-9

Author

Gödel, Clemens ; Kunkel, Birgit ; Kashani, Alireza ; Lassmann, Hans ; Arumugam, Manimozhiyan ; Krishnamoorthy, Gurumoorthy. / Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease. I: Journal of Neuroinflammation. 2020 ; Bind 17, Nr. 1. s. 79.

Bibtex

@article{cbcf5996f89941a8a9ef4863174c48c1,
title = "Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease",
abstract = "The gut microbiota regulates the host immune and nervous systems and plays an important role in the pathogenesis of autoimmune neurological disease multiple sclerosis (MS). There are considerable efforts currently being undertaken to develop therapies for MS based on the modulation of microbiota. Evidence from experimental models suggests that the manipulation of microbiota through diet or antibiotics prior to the disease development limits disease susceptibility. However, it is currently unclear if microbiota manipulation therapies would also have an impact on ongoing neurological disease. Here, we examined the effect of antibiotic-based microbiota modulation in spontaneous experimental autoimmune encephalomyelitis (EAE) mouse models of MS before and after the onset of autoimmune disease. Prophylactic antibiotic treatment led to a significant reduction of susceptibility to spontaneous EAE. In contrast, antibiotic treatment after the onset of spontaneous EAE did not show a significant amelioration. These results reveal that the perturbation of gut bacteria alters disease susceptibility but has minimal impact on the ongoing neurological disease.",
author = "Clemens G{\"o}del and Birgit Kunkel and Alireza Kashani and Hans Lassmann and Manimozhiyan Arumugam and Gurumoorthy Krishnamoorthy",
year = "2020",
doi = "10.1186/s12974-020-01766-9",
language = "English",
volume = "17",
pages = "79",
journal = "Journal of Neuroinflammation",
issn = "1742-2094",
publisher = "BioMed Central",
number = "1",

}

RIS

TY - JOUR

T1 - Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease

AU - Gödel, Clemens

AU - Kunkel, Birgit

AU - Kashani, Alireza

AU - Lassmann, Hans

AU - Arumugam, Manimozhiyan

AU - Krishnamoorthy, Gurumoorthy

PY - 2020

Y1 - 2020

N2 - The gut microbiota regulates the host immune and nervous systems and plays an important role in the pathogenesis of autoimmune neurological disease multiple sclerosis (MS). There are considerable efforts currently being undertaken to develop therapies for MS based on the modulation of microbiota. Evidence from experimental models suggests that the manipulation of microbiota through diet or antibiotics prior to the disease development limits disease susceptibility. However, it is currently unclear if microbiota manipulation therapies would also have an impact on ongoing neurological disease. Here, we examined the effect of antibiotic-based microbiota modulation in spontaneous experimental autoimmune encephalomyelitis (EAE) mouse models of MS before and after the onset of autoimmune disease. Prophylactic antibiotic treatment led to a significant reduction of susceptibility to spontaneous EAE. In contrast, antibiotic treatment after the onset of spontaneous EAE did not show a significant amelioration. These results reveal that the perturbation of gut bacteria alters disease susceptibility but has minimal impact on the ongoing neurological disease.

AB - The gut microbiota regulates the host immune and nervous systems and plays an important role in the pathogenesis of autoimmune neurological disease multiple sclerosis (MS). There are considerable efforts currently being undertaken to develop therapies for MS based on the modulation of microbiota. Evidence from experimental models suggests that the manipulation of microbiota through diet or antibiotics prior to the disease development limits disease susceptibility. However, it is currently unclear if microbiota manipulation therapies would also have an impact on ongoing neurological disease. Here, we examined the effect of antibiotic-based microbiota modulation in spontaneous experimental autoimmune encephalomyelitis (EAE) mouse models of MS before and after the onset of autoimmune disease. Prophylactic antibiotic treatment led to a significant reduction of susceptibility to spontaneous EAE. In contrast, antibiotic treatment after the onset of spontaneous EAE did not show a significant amelioration. These results reveal that the perturbation of gut bacteria alters disease susceptibility but has minimal impact on the ongoing neurological disease.

U2 - 10.1186/s12974-020-01766-9

DO - 10.1186/s12974-020-01766-9

M3 - Journal article

C2 - 32143718

VL - 17

SP - 79

JO - Journal of Neuroinflammation

JF - Journal of Neuroinflammation

SN - 1742-2094

IS - 1

ER -

ID: 239265901